|
- 2019
What outcomes are important to patients with mild cognitive impairment or Alzheimer's disease, their caregivers, and health-care professionals? A?systematic reviewDOI: 10.1016/j.dadm.2018.12.003 Keywords: Alzheimer's Disease, Mild cognitive impairment, Outcomes, Systematic review, Qualitative, Quantitative, Quality of life, Memory, Activities of daily living, Autonomy, Burden, Patients, Caregivers, Healthcare professionals Abstract: Clinical trials involving patients with Alzheimer's disease (AD) continue to try to identify disease-modifying treatments. Although trials are designed to meet regulatory and registration requirements, many do not measure outcomes of the disease most relevant to key stakeholders
|